Skip to main content
OpenTrials

Clinical trial condition

Leukemia, T-Cell

Explore clinical trials studying Leukemia, T-Cell. Study availability and eligibility vary by location and protocol.

144 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, T-Cell trial results

Completed

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

NCT03226119

Conditions
Central Nervous System Diseases, Central Nervous System Infections, Deltaretrovirus Infections, +28 more
Locations
  • LABS, Inc. Philadelphia, Pennsylvania, United States
  • Qualtex Laboratories San Antonio, Texas, United States
  • Eastern Virginia Medical School (EVMS) Norfolk, Virginia, United States
View Trial Details
Completed

Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer

NCT00898079

Conditions
Acute Undifferentiated Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Bone Marrow Diseases, +43 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 192 locations
View Trial Details
Completed

A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma

NCT01724177

Conditions
Adult T-Cell Leukemia-Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • Ehime University Hospital Tōon, Ehime, Japan
  • Iwate Medical University Hospital Morioka, Iwate, Japan
View all 18 locations
View Trial Details
Completed

Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia

NCT00278213

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations
  • Allgemeines Krankenhaus - Universitatskliniken Vienna, Austria
  • Hanuschkrankenhaus Vienna, Austria
  • Allgemeinen Krankenhaus Celle Kinderklinik Celle, Germany
  • St. Johannes Hospital - Medical Klinik II Duisburg, Germany
View all 19 locations
View Trial Details
Completed

Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma

NCT01567709

Conditions
Adult B Acute Lymphoblastic Leukemia, Adult T Acute Lymphoblastic Leukemia, Anaplastic Large Cell Lymphoma, +84 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States
View Trial Details

Related conditions